AAAAAA

   
Results: 1-8 |
Results: 8
Differential DM20 mRNA expression distinguishes two distinct patterns of spontaneous recovery from murine autoimmune encephalomyelitis
Authors: Mathisen, PM Kawczak, JA Yu, M Johnson, JM Tuohy, VK
Citation: Pm. Mathisen et al., Differential DM20 mRNA expression distinguishes two distinct patterns of spontaneous recovery from murine autoimmune encephalomyelitis, J NEUROSC R, 64(5), 2001, pp. 542-551
Pre-emptive targeting of the epitope spreading cascade with genetically modified regulatory T cells during autoimmune demyelinating disease
Authors: Yin, L Yu, M Edling, AE Kawczak, JA Mathisen, PM Nanavati, T Johnson, JM Tuohy, VK
Citation: L. Yin et al., Pre-emptive targeting of the epitope spreading cascade with genetically modified regulatory T cells during autoimmune demyelinating disease, J IMMUNOL, 167(11), 2001, pp. 6105-6112
Modulation of the IL-10/IL-12 cytokine circuit by interferon-beta inhibitsthe development of epitope spreading and disease progression in murine autoimmune encephalomyelitis
Authors: Tuohy, VK Yu, M Yin, L Mathisen, PM Johnson, JM Kawczak, JA
Citation: Vk. Tuohy et al., Modulation of the IL-10/IL-12 cytokine circuit by interferon-beta inhibitsthe development of epitope spreading and disease progression in murine autoimmune encephalomyelitis, J NEUROIMM, 111(1-2), 2000, pp. 55-63
Regression and spreading of self-recognition during the development of autoimmune demyelinating disease
Authors: Tuohy, VK Yu, M Yin, L Kawczak, JA Kinkel, RP
Citation: Vk. Tuohy et al., Regression and spreading of self-recognition during the development of autoimmune demyelinating disease, J AUTOIMMUN, 13(1), 1999, pp. 11-20
Th2 T cells expressing transgene PDGF-A serve as vectors for gene therapy in autoimmune demyelinating disease
Authors: Mathisen, PM Yu, M Yin, L Johnson, JM Kawczak, JA Nishiyama, A Tuohy, VK
Citation: Pm. Mathisen et al., Th2 T cells expressing transgene PDGF-A serve as vectors for gene therapy in autoimmune demyelinating disease, J AUTOIMMUN, 13(1), 1999, pp. 31-38
Treatment with BBB022A or rolipram stabilizes the blood-brain barrier in experimental autoimmune encephalomyelitis: an additional mechanism for the therapeutic effect of type IV phosphodiesterase inhibitors
Authors: Folcik, VA Smith, T O'Bryant, S Kawczak, JA Zhu, B Sakurai, H Kajiwara, A Staddon, JM Glabinski, A Chernosky, AL Tani, M Johnson, JM Tuohy, VK Rubin, LL Ransohoff, RM
Citation: Va. Folcik et al., Treatment with BBB022A or rolipram stabilizes the blood-brain barrier in experimental autoimmune encephalomyelitis: an additional mechanism for the therapeutic effect of type IV phosphodiesterase inhibitors, J NEUROIMM, 97(1-2), 1999, pp. 119-128
Spontaneous regression of primary autoreactivity during chronic progression of experimental autoimmune encephalomyelitis and multiple sclerosis
Authors: Tuohy, VK Yu, M Yin, L Kawczak, JA Kinkel, RP
Citation: Vk. Tuohy et al., Spontaneous regression of primary autoreactivity during chronic progression of experimental autoimmune encephalomyelitis and multiple sclerosis, J EXP MED, 189(7), 1999, pp. 1033-1042
Visinin-like protein (VILIP) is a neuron-specific calcium-dependent double-stranded RNA-binding protein
Authors: Mathisen, PM Johnson, JM Kawczak, JA Tuohy, VK
Citation: Pm. Mathisen et al., Visinin-like protein (VILIP) is a neuron-specific calcium-dependent double-stranded RNA-binding protein, J BIOL CHEM, 274(44), 1999, pp. 31571-31576
Risultati: 1-8 |